Pancreatic cancer, what kind of tests should I have run
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Reviewed by Dr. Chris Apfel, MD/PhD (UCSF)
Tests for Pancreatic Cancer: What to Expect
I'm glad you're asking about this—understanding what tests your care team recommends is an important part of your treatment planning. Let me walk you through the main tests used for pancreatic cancer.
Imaging Tests (Pictures of Your Pancreas)
According to NCCN Guidelines, imaging is the most important first step. Your doctors will likely use:
Pancreatic Protocol CT or MRI Scan
- This is the standard imaging test that best shows if there's a tumor and where it's located
- CT scan: Takes detailed cross-sectional pictures using X-rays; takes several minutes
- MRI scan: Uses magnetic fields and radio waves; takes 30-90 minutes but may show small tumors better than CT
- You'll receive contrast (dye) injected into your vein to make images clearer
Additional Imaging (if needed)
- CT of your chest and pelvis to check if cancer has spread
- PET/CT scan (combines imaging with a radioactive tracer) if distant spread wasn't found on the first scan
- MRI of the liver if CT doesn't clearly show spread
Blood Tests
Liver Function Tests
- Measure proteins, enzymes, and bilirubin (a chemical that makes bile yellow)
- Help show if the pancreas is blocking bile ducts
- Important for treatment planning
CA 19-9 Tumor Marker
- This is a protein that pancreatic cancer cells release into the bloodstream
- Important to know: High CA 19-9 can mean cancer is present, BUT it's not perfect:
- Some people with pancreatic cancer have normal CA 19-9 levels
- High levels can also be caused by other conditions (blocked bile ducts, gallstones, pancreatitis)
- Your team will track this over time to see if treatment is working
According to NCCN Guidelines, these blood tests are essential for staging and treatment planning.
Biopsy (Tissue Sample)
A biopsy is the only way to confirm you have cancer. Your doctor will collect tissue samples for testing. Methods include:
EUS-Guided Biopsy (preferred method)
- An endoscope (thin flexible tube with camera) is guided through your mouth down to your stomach
- An ultrasound probe on the tip creates detailed images of the pancreas
- A needle can collect tissue samples through the scope
- Less invasive than other methods
Imaging-Guided Biopsy
- A needle is guided through your skin using CT or ultrasound
- Often used if cancer has spread to the liver
Note: If surgery will be your first treatment, your doctor may collect the biopsy sample during surgery instead.
Endoscopic Tests (Looking Inside)
Endoscopic Ultrasound (EUS)
- Combines an endoscope with ultrasound to see the pancreas clearly
- Can help stage the cancer and obtain tissue samples
- Requires fasting and sedation
ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Mainly used to treat blocked bile ducts
- Can also help identify cancer growth
- Allows doctors to place a stent (small tube) to keep ducts open
Laparoscopy
- A surgeon makes small cuts in your abdomen and inserts a camera
- Used if your team suspects cancer has spread but imaging didn't show it
- Requires general anesthesia
Genetic Testing
According to NCCN Guidelines, all pancreatic cancer patients should have genetic testing. This includes:
Germline Testing (inherited mutations)
- Blood or saliva sample tests for inherited gene mutations
- Checks for mutations in genes like BRCA1, BRCA2, PALB2, and others
- Important because some inherited mutations qualify you for specific treatments
- Helps identify if family members are at risk
Molecular/Tumor Profiling (biomarker testing)
- Tests the cancer cells themselves for specific mutations
- Currently done mainly for advanced and metastatic pancreatic cancer
- Can identify mutations like:
- KRAS mutations (found in ~87% of pancreatic cancers)
- BRCA mutations (qualify for PARP inhibitors)
- Microsatellite instability (may qualify for immunotherapy)
- NTRK, RET, or HER2 alterations (have targeted treatments available)
According to CancerPatientLab expert Dr. [removed] Strickler, "Every pancreatic cancer patient should ask their doctor: 'Have you done the molecular profiling on my cancer? Can I see the report?'"
Questions to Ask Your Care Team
Based on NCCN Guidelines, here are important questions:
- Which tests will I have, and in what order?
- Do any of these tests have risks I should know about?
- What do I need to do to prepare for each test?
- How soon will I get results, and who will explain them to me?
- Can I get copies of my pathology report and all test results?
- Have you done genetic testing and molecular profiling on my cancer?
- Will I have access to an online patient portal with my results?
Why This Matters
These tests serve three critical purposes:
- Confirm you have pancreatic cancer
- Stage the cancer (how far it has spread)
- Identify specific mutations that may qualify you for targeted treatments
According to NCCN Guidelines, a highly experienced multidisciplinary team at a high-volume cancer center should manage your care and decide which tests and treatments are right for your specific situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ